Diffuse expression of hRFI is correlated with blood vessel invasion in gastric carcinoma

Japanese Journal of Clinical Oncology

Volumn 34, Issue 10, 2004, Pages 584-587

  Sasaki, Shin ^a   Kitayama, Joji ^a   Watanabe, Toshiaki ^a   Konishi, Tsuyoshi ^a   Nagawa, Hirokazu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Gastric carcinoma; Inhibitor of apoptosis protein; Oncogene; Vessel invasion

Indexed keywords

ANTIBODY; HUMAN RING FINGER INHIBITOR PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; UNCLASSIFIED DRUG; CARRIER PROTEIN; PROTEIN; RNF34 PROTEIN, HUMAN;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CLINICAL OBSERVATION; CLINICAL STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; STOMACH CARCINOMA; SURVIVAL RATE; VASCULAR TUMOR; ADENOCARCINOMA; BIOSYNTHESIS; LYMPH NODE; LYMPH NODE METASTASIS; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; STOMACH; STOMACH TUMOR; VASCULARIZATION;

ADENOCARCINOMA; AGED; CARRIER PROTEINS; FEMALE; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROTEINS; STOMACH; STOMACH NEOPLASMS; VASCULAR NEOPLASMS;

EID: 16644364014     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/hyh106     Document Type: Article

References (12)

1. Sasaki S, Nakamura T, Arakawa H, Mori M, Watanebe T. Nagawa H, et al. Isolation and characterization of a novel gene, hRFI, preferentially expressed in esophageal cancer. Oncogene 2002;21:5024-30.
2. Syken J, De-Medina T, Munger K. TID1, a human homolog of the Drosophila tumor suppressor 1(2)tid, encodes two mitochondrial modulators of apoptosis with opposing functions. Proc Natl Acad Sci USA 1999;96:8499-504.
3. Birnbaum MJ, Clem RJ, Miller LK. An apoptosis-inhibiting gene from a nuclear polyhedrosis virus encoding a polypeptide with Cys/His sequence motifs. J Virol 1994;68:2521-8.
4. Takahashi R, Deveraux Q, Tamm I, Welsh K, Assa-Munt N, Salvesen GS, et al. A single BIR domain of XIAP sufficient for inhibiting caspases. J Biol Chem 1998;273:7787-90.
5. Sasaki S, Watanabe T, Konishi T, Kitayama J, Nagawa H. Effects of expression of hRFI on adenoma formation and tumor progression in colorectal adenoma-careinoma sequence. J Exp Clin Cancer Res (in press).
6. Hermanek P, Sobin LH, editors. UICC TNM Classification of Malignant Tumors. 4th edition. Berlin: Springer 1987.
7. Koga S, Takebayashi M, Kaibara N, Nishidoi H, Kimura O, Kawasumi H, et al. Pathological characteristics of gastric cancer that develop hematogenous recurrence, with special reference to the site of recurrence. J Surg Oncol 1987:36:239-42.
8. Yoo CH, Noh SH, Shin DW, Choi SH, Min JS. Recurrence following curative resection for gastric carcinoma. Br J Surg 2000;87:236-42.
9. Ohno S. Fujii T, Ueda S, Nakamoto T. Kinugasa S, Yoshimum H. et al. Predictive factors and timing for liver recurrence after curative resection of gastric carcinoma. Am J Surg 2003:185:258-63.
10. Tomimatsu S, Ichikura T, Mochizuki H. Significant correlation between expression of interleukin-1 alpha and liver metastasis in gastric carcinoma. Cancer 2001;91:1272-6.
11. Amemiya H, Kono K. Itakura J. Tang RF, Takahashi A. An FQ, et al. c-Met expression in gastric cancer with liver metastasis. Oncology 2002;63:286-96.
12. Ougolkov A, Yamashita K, Bilim V, Takahashi Y, Mai M, Minamoto T. Abnormal expression of E-cadherin, beta-catenin, and c-erbB-2 in advanced gastric cancer: its association with liver metastasis. Int J Colorectal Dis 2003;18:160-6.